SGMS1
SGMS1 (sphingomyelin synthase 1, also known as SMS1, MOB or TMEM23) is the major sphingomyelin synthase at the Golgi apparatus. It transfers a phosphocholine head group from phosphatidylcholine to ceramide, forming sphingomyelin and diacylglycerol. Browse Assay Genie's current range of SGMS1 research reagents below, or read on for the biology behind the target.
SGMS1 catalyses the reversible transfer of a phosphocholine moiety in sphingomyelin (SM) biosynthesis. In the forward reaction it moves the phosphocholine head group of phosphatidylcholine (PC) onto ceramide (CER), giving SM and diacylglycerol (DAG) as a by-product. In the reverse reaction it transfers phosphocholine from SM to DAG to form PC and CER. The direction depends on the levels of CER and DAG in Golgi membranes. The enzyme does not use free phosphorylcholine or CDP-choline as a donor, and it can also transfer the phosphoethanolamine head group of phosphatidylethanolamine onto ceramide to form ceramide phosphoethanolamine.
In the Golgi, SGMS1 converts newly synthesised ceramide, delivered from the endoplasmic reticulum to the trans-Golgi by the ceramide transport protein CERT, into SM. It can form a heteromeric complex with glucosylceramide synthase (GCS), which increases sphingomyelin synthase activity and reduces glucosylceramide synthesis. This is a critical mechanism controlling the metabolic fate of ceramide in the Golgi. Through its effects on mitogenic DAG, proapoptotic ceramide and SM, a structural component of membrane rafts that act as platforms for signal transduction and protein sorting, it regulates receptor-mediated signalling. It also contributes to secretory transport by regulating the DAG pool at the Golgi and its downstream effects on PRKD1.
The SGMS1 gene encodes a protein predicted to be a five-pass transmembrane protein, and it may be predominantly expressed in brain. The protein belongs to the sphingomyelin synthase family and the HGNC gene group of sterile alpha motif domain containing proteins. Its UniProt name is phosphatidylcholine:ceramide cholinephosphotransferase 1, and an earlier gene name was transmembrane protein 23 (TMEM23). Mouse and rat both carry an orthologous Sgms1 gene.
SGMS1 converts ceramide to sphingomyelin at the Golgi, making it a central enzyme for studying the metabolic fate of ceramide.
Sphingomyelin is a structural component of membrane rafts, so SGMS1 is relevant to platforms for signal transduction and protein sorting.
By balancing mitogenic diacylglycerol and proapoptotic ceramide, SGMS1 regulates receptor-mediated signal transduction.
SGMS1 shapes the Golgi diacylglycerol pool, which affects secretory transport through downstream effects on PRKD1.
SGMS1 is the major sphingomyelin synthase at the Golgi apparatus. It transfers phosphocholine from phosphatidylcholine to ceramide, producing sphingomyelin and diacylglycerol, and can run the reaction in reverse. The direction depends on ceramide and diacylglycerol levels in Golgi membranes.
SGMS1 is also called sphingomyelin synthase 1, SMS1, MOB, MGC17342 and TMEM23, the last reflecting its former name, transmembrane protein 23. UniProt lists it as phosphatidylcholine:ceramide cholinephosphotransferase 1, EC 2.7.8.27. It belongs to the sphingomyelin synthase family.
Yes. Mouse and rat each have an orthologous gene named Sgms1. These are useful for studying sphingomyelin synthesis in vivo, but check the datasheet of any product for its validated reactivity.
Sphingolipid-metabolism enzymes, ceramide transport proteins and Golgi signalling partners with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q86VZ5; product specifications from Assay Genie datasheets.